Research Progress on Adjuvant Therapy and Traditional Chinese Medicine Effects after Radical Surgery for Stage Ⅲa Non-small Cell Lung Cancer
Non small cell lung cancer(NSCLC)accounts for 80%～85%of lung cancer cases,and about one-third of patients are already locally advanced(stage Ⅲa/Ⅲb)at the time of initial diagnosis.For stage Ⅲa patients who can be surgically resected,simple surgery still has a high recurrence and mortality rate,with a 5-year survival rate of only 23%.Therefore,in order to prevent postoperative recurrence and metastasis of stage Ⅲa NSCLC,adjuvant therapy is becoming increasingly important.Currently,the main treatment methods include chemotherapy,radiotherapy,target-ed therapy,immunotherapy,etc.In recent years,the exploration of the comprehensive treatment mode of traditional Chinese medicine is expected to reduce postoperative recurrence and metastasis,thereby improving the survival of lung cancer patient
radical surgery for stage Ⅲa non-small cell lung cancerAdjuvant therapyTraditional Chinese Med-icine Treatment
万方数据
维普
